Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation. (Q46493222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Amanda F Saltzman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Suhong Luo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Kenneth D Carson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Robert L Grubb

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

M'Liss A Hudson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

30 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

330.e9-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Racial and ethnic disparities in the receipt of cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Racial disparities in urologic health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Clinical characteristics in black and white men with prostate cancer in an equal access medical center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Should African-American men be tested for prostate carcinoma at an earlier age than white men?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

American Cancer Society guideline for the early detection of prostate cancer: update 2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Prostate specific antigen best practice statement: 2009 update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Cancer statistics for African Americans, 2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Do Gleason patterns 3 and 4 prostate cancer represent separate disease states?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Predictors of Gleason score upgrading in a large African-American population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Active surveillance for prostate cancer: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Active surveillance of prostate cancer in African American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Prostate-cancer mortality at 11 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.03.018

10.1016/J.UROLONC.2015.03.018

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25937424%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference